# Nervous System-on-Chip: Innovative Microfluidic Platform to Compartmentalize hiPSC-Derived Neural Networks

**Authors:** Rahman Sabahi-Kaviani, Antigoni Gogolou, Celine Souilhol, Mark van der Kroeg, Steven A. Kushner, Femke M. S. de Vrij, Anestis Tsakiridis, Regina Luttge

PMC · DOI: 10.3390/mi17020199 · Micromachines · 2026-02-01

## TL;DR

This paper introduces a microfluidic platform called Nervous System-on-Chip to grow and study human neural networks in a controlled environment.

## Contribution

The study introduces a novel microfluidic platform using microtunnel devices to compartmentalize and culture human iPSC-derived neural networks.

## Key findings

- Microtunnel devices enable axonal growth while restricting soma and dendrite migration between compartments.
- The platform supports the formation of viable, organized cortical and enteric neural networks.
- The system shows potential for modeling human nervous system biology and studying neurodegenerative diseases.

## Abstract

This study presents the development of a Nervous System-on-Chip (NoC) using microfabrication techniques, focusing on the integration of human induced pluripotent stem cell (hiPSC)-derived neurons. We designed and fabricated NoCs based on microtunnel devices (MDs) with radial and linear configurations to facilitate the compartmentalized culture of cortical and enteric neural networks. Our findings demonstrate that these MDs allow axonal growth while restricting migration of somas and dendrites between compartments, thereby promoting the formation of organized neural networks. This creates a microfluidic platform capable of supporting the growth of different culture systems, which could potentially be combined to study interactions between the central and enteric nervous systems. The resulting neuronal networks exhibited viability, expression of key lineage markers, and synapse formation, highlighting the platform’s potential for advanced nervous system modeling. MD-based NoC models provide an innovative microfluidic platform for studying the biology of human neural networks, with implications for the investigation of neurodegenerative diseases such as Parkinson’s Disease and applications in pre-clinical research.

## Linked entities

- **Diseases:** Parkinson’s Disease (MONDO:0005180)

## Full-text entities

- **Genes:** CD24 (CD24 molecule) [NCBI Gene 100133941] {aka CD24A}, HTR2A (5-hydroxytryptamine receptor 2A) [NCBI Gene 3356] {aka 5-HT2A, HTR2}, INHBE (inhibin subunit beta E) [NCBI Gene 83729], TUBB3 (tubulin beta 3 class III) [NCBI Gene 10381] {aka CDCBM, CDCBM1, CFEOM3, CFEOM3A, FEOM3, TUBB4}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, PRPH (peripherin) [NCBI Gene 5630] {aka NEF4, PRPH1}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, NGFR (nerve growth factor receptor) [NCBI Gene 4804] {aka CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, CHAT (choline O-acetyltransferase) [NCBI Gene 1103] {aka CHOACTASE, CMS1A, CMS1A2, CMS6}, NODAL (nodal growth differentiation factor) [NCBI Gene 4838] {aka HTX5}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 6663] {aka DOM, PCWH, SOX-10, WS2E, WS4, WS4C}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, S100B (S100 calcium binding protein B) [NCBI Gene 6285] {aka NEF, S100, S100-B, S100beta}, NEFH (neurofilament heavy chain) [NCBI Gene 4744] {aka CMT2CC, NFH}, ASCL1 (achaete-scute family bHLH transcription factor 1) [NCBI Gene 429] {aka ASH1, HASH1, MASH1, bHLHa46}, MRAP (melanocortin 2 receptor accessory protein) [NCBI Gene 56246] {aka B27, C21orf61, FALP, GCCD2, MRAP1}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, PHOX2B (paired like homeobox 2B) [NCBI Gene 8929] {aka CCHS, NBLST2, NBPhox, PMX2B}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}, GDNF (glial cell derived neurotrophic factor) [NCBI Gene 2668] {aka ATF, ATF1, ATF2, HFB1-GDNF, HSCR3}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}
- **Diseases:** brain disorders (MESH:D001927), mycoplasma (MESH:D009175), Cytotoxicity (MESH:D064420), neuronal injury (MESH:D009410), NoC (MESH:D009422), MD (MESH:D009471), PD (MESH:D010300), conditions (MESH:D020763), neurodevelopmental diseases (MESH:D004194), NDDs (MESH:D019636), injury to (MESH:D014947), neurological disease (MESH:D020271), karyotypic abnormalities (MESH:D059786)
- **Chemicals:** RA (MESH:D014212), Alexa-647 (MESH:C569686), penicillin (MESH:D010406), aluminum (MESH:D000535), D600L430 (-), Si (MESH:D012825), Hoechst 33342 (MESH:C017807), PFA (MESH:C003043), SB-431542 (MESH:C459179), PDMS (MESH:C013830), CO2 (MESH:D002245), DAPI (MESH:C007293), quartz (MESH:D011791), formaldehyde (MESH:D005557), dibutyryl cyclic adenosine monophosphate (MESH:D003994), poly-L-ornithine (MESH:C008973), oxygen (MESH:D010100), NaCl (MESH:D012965), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), N2 (MESH:D009584), F12 (MESH:C007782), EDTA (MESH:D004492), CHIR99021 (MESH:C473711), PMMA (MESH:D019904), ethanol (MESH:D000431), GlutaMAX (MESH:C054122), essential amino acid (MESH:D000601), ascorbic acid (MESH:D001205)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** K1050X, (L) from 100
- **Cell lines:** SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), WTC-11 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_Y803)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942585/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942585/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942585/full.md

---
Source: https://tomesphere.com/paper/PMC12942585